Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice

Fig. 1

Effect of melatonin on body weight and liver mass. (A) Body weight (g) of HFD with melatonin, HFD, RD with melatonin and RD during 36 weeks, n = 6 mice/group. (B) Liver mass of HFD with melatonin, HFD, RD with melatonin and RD at the end of treatment, n = 6 mice/group. *P < 0.05 for group A vs group B; #P < 0.05 for group B vs group D

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X